Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease.
Moreker
Mayur R
MR
Lodhi
Sikander A
SA
Pathengay
Avinash
A
D000293:Adolescent; D000328:Adult; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008875:Middle Aged; D012074:Remission Induction / Q000379:methods; D013997:Time Factors; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014607:Uveomeningoencephalitic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide